JP2010285450A5 - - Google Patents

Download PDF

Info

Publication number
JP2010285450A5
JP2010285450A5 JP2010176824A JP2010176824A JP2010285450A5 JP 2010285450 A5 JP2010285450 A5 JP 2010285450A5 JP 2010176824 A JP2010176824 A JP 2010176824A JP 2010176824 A JP2010176824 A JP 2010176824A JP 2010285450 A5 JP2010285450 A5 JP 2010285450A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010176824A
Other versions
JP2010285450A (ja
JP5363432B2 (ja
Filing date
Publication date
Priority claimed from EP19990201204 external-priority patent/EP1046651A1/en
Application filed filed Critical
Publication of JP2010285450A publication Critical patent/JP2010285450A/ja
Publication of JP2010285450A5 publication Critical patent/JP2010285450A5/ja
Application granted granted Critical
Publication of JP5363432B2 publication Critical patent/JP5363432B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010176824A 1999-04-19 2010-08-05 樹状細胞−ｔ細胞の相互作用を調節するための組成物及び方法 Expired - Fee Related JP5363432B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99201204.7 1999-04-19
EP19990201204 EP1046651A1 (en) 1999-04-19 1999-04-19 Composition and method for modulating dendritic cell-T interaction
US17692400P 2000-01-20 2000-01-20
US60/176,924 2000-01-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000612337A Division JP4989820B2 (ja) 1999-04-19 2000-04-19 樹状細胞−ｔ細胞の相互作用を調節するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2010285450A JP2010285450A (ja) 2010-12-24
JP2010285450A5 true JP2010285450A5 (ja) 2011-08-18
JP5363432B2 JP5363432B2 (ja) 2013-12-11

Family

ID=8240111

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000612337A Expired - Fee Related JP4989820B2 (ja) 1999-04-19 2000-04-19 樹状細胞−ｔ細胞の相互作用を調節するための組成物及び方法
JP2010176824A Expired - Fee Related JP5363432B2 (ja) 1999-04-19 2010-08-05 樹状細胞−ｔ細胞の相互作用を調節するための組成物及び方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000612337A Expired - Fee Related JP4989820B2 (ja) 1999-04-19 2000-04-19 樹状細胞−ｔ細胞の相互作用を調節するための組成物及び方法

Country Status (14)

Country Link
US (4) US7148329B1 (ja)
EP (3) EP1046651A1 (ja)
JP (2) JP4989820B2 (ja)
KR (3) KR100952883B1 (ja)
AT (2) ATE398140T1 (ja)
AU (1) AU776317B2 (ja)
CA (1) CA2330231C (ja)
DE (2) DE60044621D1 (ja)
DK (2) DK1086137T3 (ja)
ES (2) ES2346877T3 (ja)
HK (1) HK1036285A1 (ja)
NZ (1) NZ508723A (ja)
PT (2) PT1086137E (ja)
WO (1) WO2000063251A1 (ja)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1046651A1 (en) * 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
US6515124B2 (en) * 2000-02-09 2003-02-04 Hoffman-La Roche Inc. Dehydroamino acids
NZ534864A (en) * 2000-05-08 2006-04-28 Celldex Therapeutics Inc Human monoclonal antibodies to dentritic cells
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
CA2431990A1 (en) * 2000-12-21 2002-06-27 Stichting Katholieke Universiteit Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
US20030013081A1 (en) 2001-06-26 2003-01-16 Olson William C. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
US7022323B2 (en) 2001-06-26 2006-04-04 Progenics Pharmaceuticals, Inc. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
ES2197826B1 (es) * 2002-06-21 2005-04-01 Consejo Superior De Investigaciones Cientificas Compuesto terapeutico frente a la infeccion por leishmania y su uso.
WO2004026326A2 (en) * 2002-09-20 2004-04-01 Stichting Katholieke Universiteit Antigen uptake receptor for candida albicans on dendritic cells
US7691591B2 (en) * 2002-09-20 2010-04-06 Stichting Katholieke Universiteit Methods of identifying and isolating cells expressing DC-sign
US20040146948A1 (en) * 2002-10-18 2004-07-29 Centenary Institute Of Cancer Medicine And Cell Biology Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments
US7427469B2 (en) 2002-11-05 2008-09-23 Institut Pasteur Method of treating cytomegalovirus with DC-SIGN blockers
EP1562628B1 (en) * 2002-11-05 2009-04-15 Institut Pasteur Dc-sign blockers and their use for preventing or treating viral infections.
EP1417965A1 (en) * 2002-11-07 2004-05-12 Vereniging Voor Christelijk Wetenschappelijk Onderwijs C-type lectin binding molecules, identification and uses thereof
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
EP1594533B1 (en) 2003-01-31 2012-04-11 Celldex Research Corporation Antibody vaccine conjugates and uses therefor
JP5021309B2 (ja) * 2003-10-16 2012-09-05 ステファン ジョン ラルフ 免疫調節性組成物およびその使用方法
AU2011211337B2 (en) * 2003-10-16 2014-10-02 Cancure Limited Immunomodulating compositions and uses therefor
US20080025913A1 (en) * 2003-12-15 2008-01-31 Bowdish Katherine S Novel Anti-Dc-Sign Antibodies
EP1761248B1 (en) 2004-03-19 2012-05-23 Rodos BioTarget GmbH Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds
DK1765294T3 (da) * 2004-05-12 2008-11-10 Baxter Int Nukleinsyremikrokugler samt deres fremstilling og afgivelse
US7884085B2 (en) * 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP2963118B1 (en) 2005-06-01 2017-08-09 California Institute of Technology Method of targeted gene delivery using viral vectors
FR2895262B1 (fr) * 2005-12-22 2009-07-17 Lab Francais Du Fractionnement Inhibition de la reponse immunitaire anti-fviii
AT503387B1 (de) * 2006-03-27 2008-05-15 Univ Wien Pharmazeutische zusammensetzung zur vorbeugung von infektionen
WO2008011636A2 (en) * 2006-07-21 2008-01-24 California Institute Of Technology Targeted gene delivery for dendritic cell vaccination
AU2008214077B2 (en) * 2007-02-02 2012-12-13 Baylor Research Institute Multivariable antigens complexed with targeting humanized monoclonal antibody
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
NZ578696A (en) 2007-02-02 2012-01-12 Baylor Res Inst Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
CN101970491A (zh) 2007-08-30 2011-02-09 沃尔特及伊莱萨霍尔医学研究院 树突状细胞标记物及其用途
KR20100087344A (ko) 2007-10-29 2010-08-04 버지니아 테크 인터렉추얼 프라퍼티스, 인크. 돼지 ＤＣ-ＳＩＧＮ, ＩＣＡＭ－３ 및 ＬＳＥＣｔｉｎ 및 이의 용도
KR101811965B1 (ko) 2007-11-07 2017-12-22 셀덱스 쎄라퓨틱스, 인크. 인간 수지상 및 상피 세포 205(ｄｅｃ-205)에 결합하는 항체
EP2770061B1 (en) 2009-07-24 2018-10-24 Immune Design Corp. Non-integrating lentiviral vectors
US20120322085A1 (en) * 2009-11-05 2012-12-20 Osaka University Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
JP5690132B2 (ja) 2010-06-17 2015-03-25 株式会社マーレ フィルターシステムズ エンジンの換気システム
WO2012021512A2 (en) 2010-08-10 2012-02-16 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CN104583231B (zh) 2012-03-30 2021-02-26 免疫设计公司 具有对表达dc-sign的细胞改善的转导效率的慢病毒载体粒子
US9713635B2 (en) 2012-03-30 2017-07-25 Immune Design Corp. Materials and methods for producing improved lentiviral vector particles
US8323662B1 (en) 2012-03-30 2012-12-04 Immune Design Corp. Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein
DK2833914T3 (en) * 2012-04-04 2019-03-11 Vaxform Llc ADMINISTRATIVE SYSTEM FOR ORAL VACCINE ADMINISTRATION
WO2014046994A1 (en) * 2012-09-18 2014-03-27 University Of Washington Through Its Center For Commercialization Compositions and methods for antigen targeting to cd180
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
AU2015233084B2 (en) 2014-02-21 2020-12-17 Anokion Sa Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3142691A4 (en) 2014-05-16 2018-04-11 Baylor Research Institute Methods and compositions for treating autoimmune and inflammatory conditions
US10688178B2 (en) 2015-06-30 2020-06-23 Osaka University AntiPlexin A1 agonist antibody
CN108210503A (zh) * 2016-12-10 2018-06-29 高尚先 甘露糖在用于提高Treg细胞数量及其Foxp3因子表达水平的新用途
EP3638296A1 (en) 2017-06-16 2020-04-22 The University Of Chicago Compositions and methods for inducing immune tolerance

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US891992A (en) 1907-06-27 1908-06-30 Henry Hess Method of forming conically-shaped ends upon rollers and other objects.
US5332567A (en) 1989-08-24 1994-07-26 Immunomedics Detection and treatment of infections with immunoconjugates
US6248332B1 (en) * 1990-10-05 2001-06-19 Medarex, Inc. Targeted immunostimulation with bispecific reagents
IE922308A1 (en) * 1991-07-16 1993-01-27 Bristol Myers Squibb Co Inhibition of non-cd4 mediated hiv infection
AU7339294A (en) 1993-07-22 1995-02-20 Precision Valve Corporation Multi-directional actuation overcap
US6084067A (en) 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
AUPM322393A0 (en) 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
CA2188812A1 (en) 1994-05-26 1995-12-07 Mark De Boer New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness
US5548275A (en) * 1995-01-23 1996-08-20 Shambayati; Ali Alarm system for enclosing and protecting an area
US5643786A (en) 1995-01-27 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Method for isolating dendritic cells
CA2211993A1 (en) * 1995-01-31 1996-08-08 The Rockefeller University Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
US5871964A (en) * 1996-07-15 1999-02-16 Incyte Pharmaceuticals, Inc. Human C-type lectin
US6046158A (en) * 1996-12-20 2000-04-04 Board Of Regents The University Of Texas Systems Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
US5935813A (en) * 1997-03-20 1999-08-10 Incyte Pharmaceuticals, Inc. Human pancreatitis-associated protein
WO1998049306A1 (en) * 1997-04-29 1998-11-05 Incyte Pharmaceuticals, Inc. Human c-type lectin
JP2002512524A (ja) 1997-06-03 2002-04-23 財団法人相模中央化学研究所 膜貫通ドメインを有するヒト蛋白質及びそれをコードするｄｎａ
US6273443B1 (en) * 1998-06-01 2001-08-14 Sunrise Medical Hhg Inc. Universal elevating leg rest assembly
EP1046651A1 (en) 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
WO2001012811A1 (en) * 1999-08-12 2001-02-22 Urogenesys, Inc. C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
CA2431990A1 (en) 2000-12-21 2002-06-27 Stichting Katholieke Universiteit Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
US20030232745A1 (en) * 2001-06-26 2003-12-18 Olson William C. Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection
US7022323B2 (en) 2001-06-26 2006-04-04 Progenics Pharmaceuticals, Inc. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
US7265642B2 (en) * 2003-12-09 2007-09-04 Synergy Microwave Corporation User-definable thermal drift voltage control oscillator

Similar Documents

Publication Publication Date Title
BR112013008959A2 (ja)
BR112012031500A2 (ja)
BR112012026492A2 (ja)
BR112012027808A2 (ja)
BR112012024897A2 (ja)
BR112012025307A2 (ja)
BR112012019354A2 (ja)
BR112012002126A2 (ja)
BR112012026946A2 (ja)
BR112012017960A2 (ja)
JP2010285450A5 (ja)
BR112012025482A2 (ja)
BR112013006400A2 (ja)
BR112012031826A2 (ja)
BR112012025577A2 (ja)
BR112012023249A2 (ja)
BR112012016456A2 (ja)
BR112012018256A2 (ja)
BR112012027015A2 (ja)
BR112012025308A2 (ja)
BR112012024872A2 (ja)
BR112012023265A2 (ja)
BR112013010949A2 (ja)
BR112013003284A2 (ja)
BR112013002646A2 (ja)